Hiroki Kiyohara

9PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisGlycoconjugatesPredictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 22, 2026
Effectiveness and safety of tacrolimus versus infliximab as rescue therapy for intravenous corticosteroid-refractory acute severe ulcerative colitis: a multicenter cohort study.

|Sep 09, 2026
Diagnostic Performance and Reproducibility of Chromoendoscopic Classification (FOCUS Classification: Flat-Type Dysplasia Optical Assessment by Chromoendoscopy in Ulcerative ColitiS) for Flat-Type Dysplasia in Ulcerative Colitis-Associated Neoplasia.

|Jan 17, 2025
Leucine-rich alpha-2 glycoprotein in combination with C-reactive protein for predicting endoscopic activity in Crohn's disease: a single-centre, cross-sectional study.

Yoshiaki Takada, Hiroki Kiyohara, Yohei Mikami

|Apr 24, 2024
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.

Tomohiro Fukuda, Yasuhiro Aoki, Hiroki Kiyohara

|Apr 23, 2024
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.

Tomohiro Fukuda, Hajime Yamazaki, Yusuke Miyatani

|Jan 25, 2024
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study.

Yuta Matsubara, Hiroki Kiyohara, Yohei Mikami

Pageof 2

Frequent Collaborators

3 joint publications

Katsuyoshi Ando

3 joint publications

Kaoru Takabayashi

3 joint publications

Shinya Sugimoto

3 joint publications

Yohei Mikami